全文获取类型
收费全文 | 9581篇 |
免费 | 702篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 69篇 |
儿科学 | 391篇 |
妇产科学 | 293篇 |
基础医学 | 1090篇 |
口腔科学 | 116篇 |
临床医学 | 2120篇 |
内科学 | 1310篇 |
皮肤病学 | 105篇 |
神经病学 | 945篇 |
特种医学 | 209篇 |
外科学 | 819篇 |
综合类 | 130篇 |
一般理论 | 27篇 |
预防医学 | 1343篇 |
眼科学 | 150篇 |
药学 | 557篇 |
中国医学 | 41篇 |
肿瘤学 | 585篇 |
出版年
2023年 | 58篇 |
2022年 | 92篇 |
2021年 | 177篇 |
2020年 | 121篇 |
2019年 | 172篇 |
2018年 | 203篇 |
2017年 | 206篇 |
2016年 | 208篇 |
2015年 | 219篇 |
2014年 | 287篇 |
2013年 | 434篇 |
2012年 | 680篇 |
2011年 | 740篇 |
2010年 | 405篇 |
2009年 | 354篇 |
2008年 | 630篇 |
2007年 | 682篇 |
2006年 | 611篇 |
2005年 | 620篇 |
2004年 | 650篇 |
2003年 | 568篇 |
2002年 | 539篇 |
2001年 | 110篇 |
2000年 | 103篇 |
1999年 | 101篇 |
1998年 | 122篇 |
1997年 | 82篇 |
1996年 | 77篇 |
1995年 | 76篇 |
1994年 | 69篇 |
1993年 | 54篇 |
1992年 | 66篇 |
1991年 | 60篇 |
1990年 | 54篇 |
1989年 | 65篇 |
1988年 | 35篇 |
1987年 | 47篇 |
1986年 | 29篇 |
1985年 | 47篇 |
1984年 | 40篇 |
1983年 | 47篇 |
1982年 | 41篇 |
1981年 | 27篇 |
1980年 | 35篇 |
1979年 | 25篇 |
1978年 | 32篇 |
1977年 | 20篇 |
1975年 | 25篇 |
1974年 | 23篇 |
1971年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study. 总被引:1,自引:0,他引:1
Joanna L Perkins Yan Liu Pauline A Mitby Joseph P Neglia Sue Hammond Marilyn Stovall Anna T Meadows Ray Hutchinson Zoann E Dreyer Leslie L Robison Ann C Mertens 《Journal of clinical oncology》2005,23(16):3733-3741
PURPOSE: Nonmelanoma skin cancer (NMSC) has become the most common type of cancer in many populations throughout the world. Ultraviolet and ionizing radiation are known risk factors. Because NMSCs are rarely lethal and most cancer registries do not routinely report data regarding these cancers, they have received little attention in studies evaluating long-term effects of cancer therapy. This article reports on the occurrence of secondary NMSC as a long-term effect of cancer therapy in survivors of childhood cancer. PATIENTS AND METHODS: The Childhood Cancer Survivor Study (CCSS) is a cohort study of 5-year survivors of childhood and adolescent cancer from 25 participating institutions in North America. NMSC patients were defined by a history of basal cell or squamous cell carcinoma of the skin after primary malignancy treatment. Demographic and treatment data were collected and analyzed. RESULTS: Among the 13,132 eligible CCSS participants, 213 have reported NMSC; 99 patients (46%) have had multiple occurrences. Median age of occurrence was 31 years (range, 7 to 46 years). Location of NMSC included head and neck (43%), back (24%), chest (22%), abdomen and pelvis (5%), extremity (3%), and unknown (4%). Ninety percent of patients had previously received radiation therapy (RT); 90% of tumors occurred within the RT field. RT was associated with a 6.3-fold increase in risk (95% CI, 3.5- to 11.3-fold). CONCLUSION: Long-term survivors of childhood and adolescent cancer who were treated with RT are at highest risk for developing NMSC. Educational efforts need to be directed to this population to facilitate early diagnosis of NMSC and reduction in sun exposure. 相似文献
102.
Kyoung-Mu Lee Ji-Yeob Choi Changwon Kang Changsoo Paul Kang Sue Kyung Park Hyunmi Cho Dae-Yeon Cho Keun-Young Yoo Dong-Young Noh Sei-Hyun Ahn Chung-Gyu Park Qingyi Wei Daehee Kang 《Clinical cancer research》2005,11(12):4620-4626
PURPOSE: Genetic polymorphisms of DNA repair genes seem to determine the DNA repair capacity, which in turn may affect the risk of breast cancer. To evaluate the role of genetic polymorphisms of DNA repair genes in breast cancer, we conducted a hospital-based case-control study of Korean women. EXPERIMENTAL DESIGN: We included 872 incident breast cancer cases and 671 controls recruited from several teaching hospitals in Seoul from 1995 to 2002. Twelve loci of selected DNA repair genes were genotyped by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (XRCC2 Arg188His, XRCC4 921G > T, XRCC6 1796G > T, LIG4 1977T/C, RAD51 135G > C, 172G > T, RAD52 2259C > T, LIG1 551A > C, ERCC1 8092A > C, 354C > T, hMLH1 -93G > A, and Ile219Val). RESULTS: We found that the RAD52 2259 CT or TT, hMLH1 -93 GG, and ERCC1 8092 AA genotypes were associated with breast cancer risk after adjustment for known risk factors [odds ratio (OR), 1.33; 95% confidence interval (95% CI), 1.02-1.75; OR, 1.31; 95% CI, 0.99-1.74; and OR, 0.58; 95% CI, 0.38-0.89, respectively]. When Bonferroni's method was used to correct for multiple comparisons for nine polymorphisms with P = 0.005, all of these associations were not significant. However, the effects of RAD52 2259 CT or TT and ERCC1 354 CT or TT genotypes were more evident for the estrogen/progesterone receptor-negative cases (OR, 2.03; 95% CI, 1.24-3.34 and OR, 1.99; 95% CI, 1.35-2.94, respectively). CONCLUSION: Our findings suggest that genetic polymorphisms of RAD52, ERCC1, and hMLH1 may be associated with breast cancer risk in Korean women. 相似文献
103.
Feasibility and acceptability of a motivational interviewing breastfeeding peer support intervention
Lauren Copeland Laura Merrett Cheryl McQuire Aimee Grant Nina Gobat Sally Tedstone Rebecca Playle Sue Channon Julia Sanders Rhiannon Phillips Billie Hunter Amy Brown Deborah Fitzsimmons Michael Robling Shantini Paranjothy 《Maternal & child nutrition》2019,15(2)
An uncontrolled study with process evaluation was conducted in three U.K. community maternity sites to establish the feasibility and acceptability of delivering a novel breastfeeding peer‐support intervention informed by motivational interviewing (MI; Mam‐Kind). Peer‐supporters were trained to deliver the Mam‐Kind intervention that provided intensive one‐to‐one peer‐support, including (a) antenatal contact, (b) face‐to‐face contact within 48 hr of birth, (c) proactive (peer‐supporter led) alternate day contact for 2 weeks after birth, and (d) mother‐led contact for a further 6 weeks. Peer‐supporters completed structured diaries and audio‐recorded face‐to‐face sessions with mothers. Semistructured interviews were conducted with a purposive sample of mothers, health professionals, and all peer‐supporters. Interview data were analysed thematically to assess intervention acceptability. Audio‐recorded peer‐support sessions were assessed for intervention fidelity and the use of MI techniques, using the MITI 4.2 tool. Eight peer‐supporters delivered the Mam‐Kind intervention to 70 mothers in three National Health Service maternity services. Qualitative interviews with mothers (n = 28), peer‐supporters (n = 8), and health professionals (n = 12) indicated that the intervention was acceptable, and health professionals felt it could be integrated with existing services. There was high fidelity to intervention content; 93% of intervention objectives were met during sessions. However, peer‐supporters reported difficulties in adapting from an expert‐by‐experience role to a collaborative role. We have established the feasibility and acceptability of providing breastfeeding peer‐support using a MI‐informed approach. Refinement of the intervention is needed to further develop peer‐supporters' skills in providing mother‐centred support. The refined intervention should be tested for effectiveness in a randomised controlled trial. 相似文献
104.
The antioxidant activity of the stem bark from Albizzia julibrissin was evaluated for its potential to scavenge 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals, to inhibit the generation of the hydroxyl radical (*OH), total reactive oxygen species (ROS) and to scavenge authentic peroxynitrites (ONOO-). The methanol extract of A. julibrissin exhibited strong antioxidant activity in the tested model systems. Therefore, it was further fractionated using several solvents. The antioxidant activity of the individual fractions were in the order of ethyl acetate (EtOAc) > n-butanol (n-BuOH) > dichloromethane (CH2Cl2) > and water (H2O). The ethyl acetate soluble fraction, which exhibited strong antioxidant activity, was further purified by repeated silicagel, Sephadex LH-20 and RP-18 gel column chromatography. Sulfuretin (1) and 3',4',7-trihydroxyflavone (2) were isolated as the active principles. Compounds 1 and 2 exhibited good activity in all tested model systems. Compound 1 exhibited five times more inhibitory activity on the total ROS than Trolox. Compound 2 showed six times stronger DPPH radical scavenging activity than L-ascorbic acid. These results show the possible antioxidant activity of the A. julibrissin crude extract and its major constituents. 相似文献
105.
目的研究柳穿鱼全草的化学成分。方法利用柱色谱法分离和IR,MS及1D,2D-NMR等波谱分析法确定结构。结果鉴定18个化合物,分别为苯甲醇O-β-D-吡喃葡萄糖苷(Ⅰ),苯甲醇樱草糖苷(Ⅱ),苯甲醇O-(2'-β-O-β-D-吡喃木糖基)-β- D-吡喃葡萄糖苷(Ⅲ),3,5-二甲氧基-4-羟基苯甲醛(Ⅳ),葡萄糖丁香酸(Ⅴ),丁香苷(Ⅵ),liriodendrin(Ⅶ),2,4-二叔丁基苯酚(Ⅷ),对甲氧基苯甲酸(Ⅸ),白杨素(Ⅹ),linarioside(Ⅺ),甘露醇(Ⅻ),半乳糖醇(ⅩⅢ),丁二酸(ⅪⅤ),正二十六烷酸(ⅩⅤ).正二十七烷醇(ⅩⅥ),二十九烷醇-15(ⅩⅦ),α-单二十烷酸甘油酯(ⅩⅧ)。结论其中15个化合物(Ⅰ-Ⅴ,Ⅶ-Ⅹ,ⅩⅢ-ⅩⅧ) 为首次从柳穿鱼属植物中得到。 相似文献
106.
Kook-Hwan Oh Sue K. Park Jayoun Kim Curie Ahn Representing the KNOW-CKD Study Investigators 《Yebang Ŭihakhoe chi》2022,55(4):313
The KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD) was launched in 2011 with the support of the Korea Disease Control and Prevention Agency. The study was designed with the aim of exploring the various clinical features and characteristics of chronic kidney disease (CKD) in Koreans, and elucidating the risk factors for CKD progression and adverse outcomes of CKD. For the cohort study, nephrologists at 9 tertiary university-affiliated hospitals participated in patient recruitment and follow-up. Biostatisticians and epidemiologists also participated in the basic design and structuring of the study. From 2011 until 2016, the KNOW-CKD Phase I recruited 2238 adult patients with CKD from stages G1 to G5, who were not receiving renal replacement therapy. The KNOW-CKD Phase II recruitment was started in 2019, with an enrollment target of 1500 subjects, focused on diabetic nephropathy and hypertensive kidney diseases in patients with reduced kidney function who are presumed to be at a higher risk of adverse outcomes. As of 2021, the KNOW-CKD investigators have published articles in the fields of socioeconomics, quality of life, nutrition, physical activity, renal progression, cardiovascular disease and outcomes, anemia, mineral bone disease, serum and urine biomarkers, and international and inter-ethnic comparisons. The KNOW-CKD researchers will elaborate a prediction model for various outcomes of CKD such as the development of end-stage kidney disease, major adverse cardiovascular events, and death. 相似文献
107.
108.
John Lasekan Yong Choe Svyatoslav Dvoretskiy Amy Devitt Sue Zhang Amy Mackey Karyn Wulf Rachael Buck Christine Steele Michelle Johnson Geraldine Baggs 《Nutrients》2022,14(13)
Background: Five of the most abundant human milk oligosaccharides (HMOs) in human milk are 2′-fucosyllactose (2′-FL), 3-fucosyllactose (3-FL), lacto-N-tetraose (LNT), 3′-sialyllactose (3′-SL) and 6′-sialyllactose (6′-SL). Methods: A randomized, double-blind, controlled parallel feeding trial evaluated growth in healthy term infants fed a control milk-based formula (CF; n = 129), experimental milk-based formula (EF; n = 130) containing five HMOs (5.75 g/L; 2′-FL, 3-FL, LNT, 3′-SL and 6′-SL) or human milk (HM; n = 104). Results: No significant differences (all p ≥ 0.337, protocol evaluable cohort) were observed among the three groups for weight gain per day from 14 to 119 days (D) of age, irrespective of COVID-19 or combined non-COVID-19 and COVID-19 periods. There were no differences (p ≥ 0.05) among the three groups for gains in weight and length from D14 to D119. Compared to the CF group, the EF group had more stools that were soft, frequent and yellow and were similar to the HM group. Serious and non-serious adverse events were not different among groups, but more CF-fed infants were seen by health care professionals for illness from study entry to D56 (p = 0.044) and D84 (p = 0.028) compared to EF-fed infants. Conclusions: The study demonstrated that the EF containing five HMOs supported normal growth, gastrointestinal (GI) tolerance and safe use in healthy term infants. 相似文献
109.
OBJECTIVE: To estimate how preventive services and counseling differ for women seen by general medical physicians and gynecologists, and whether seeing both types of physicians had a greater impact on delivery of gender-specific and gender-neutral preventive care than by either type of physician alone. METHODS: Using data from the 2000 National Health Interview Survey, we studied the association of provider type with Pap tests, tobacco use screening, and exercise and diet counseling among women 18-64 years (n=7,317), and these services along with clinical breast examinations, mammograms, and colon cancer screening among women aged 50-64 years (n=1,551). We modeled care using multivariable logistic regression and used propensity score techniques to limit selection bias from choice of provider. RESULTS: In the study sample, 15% were seen by general medical physicians, 62% by gynecologists, and 23% by both. Overall rates of gender-specific services (Pap test, clinical breast examination, mammography) were high (88-95%), whereas gender-neutral services were low (23-53%). Patients of gynecologists only were more likely to have Pap tests (adjusted relative risk [RR] 1.26, 95% confidence interval [CI] 1.24-1.27), tobacco use screening (adjusted RR 1.08, 95% CI 1.02-1.14), mammography (adjusted RR 1.25, 95% CI 1.20-1.28), and clinical breast examination (adjusted RR 1.25, 95% CI 1.19-1.29). In general, combined gynecologist and general care did not increase the likelihood of preventive care. Propensity score analyses confirmed these results. CONCLUSION: Patients of gynecologists receive more preventive services compared with patients of general medical physicians, although rates of gender-neutral services were low regardless of provider type. These findings validate gynecologists' roles as providers of basic preventive care services but demonstrate that considerable room exists to improve delivery of preventive care to women. 相似文献
110.
Fejzo MS Ingles SA Wilson M Wang W MacGibbon K Romero R Goodwin TM 《European journal of obstetrics, gynecology, and reproductive biology》2008,141(1):13-17